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Background: Petroselinum crispum, a bright green biennial shrub is widely used traditionally as a food additive and
herbal remedies for many ailments. This study therefore aimed to assess the toxic effects of its leaf extract using
some biochemical, haematological parameters.
Methods: The toxic effects were assessed by quantifying liver enzymes such as serum aspartate amino transferase
(AST), alanine amino transferase (ALT), alkaline phosphatase (ALP), total serum protein and liver weight. Effects on
haematological parameters were assessed by analysis of parked cell volume (PCV), red blood cell count (RBC), white
blood cells (WBC) and haemoglobin (Hb) concentrations. Histopathological studies were done on the liver and
kidneys.
Results: The extract caused significant increase in serum activity of alanine amino transferase and blood urea
nitrogen (BUN) levels at the dose of 1000 mg/kg. Other biochemical and haematological parameters were not
affected at lower doses. Conversely, the liver weight was not affected after eight weeks of treatment at the dose
levels studied. The organs obtained for pathological study, were structurally unchanged under histopathological
evaluation at lower doses but inflammatory and necrotic features were observed at doses ≥ 1000 mg/kg.
Conclusion: The results indicate that the leaf ethanol extract of Petroselinum crispum was hepatotoxic and
nephrotoxic at continued oral doses equal to or more than 1000 mg/kg, but no obvious toxicity when used at
lower doses. Therefore, there should be caution in its administration to avoid overdosing and known interaction
with some medications. In addition, the plant should be kept away from pets and domestic animals and should not
be cultivated on soil irrigated with waste water due to their ability to bio-accumulate toxic metals.
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RatsBackground
Peteroselinum crispsum (Parsley) is a bright green,
biennial herb, which belongs to the family Apiaceae.
Native to the central Mediterranean region (Southern
Italy, Algeria and Tunisia) and naturalised elsewhere in
Europe, Africa and Asia. It is commonly used as a ganish* Correspondence: awemann@yahoo.co.uk
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distribution, and reproduction in any mediumin soups, salads, meats, vegetables and sauces [1]. Trad-
itionally, the leaf, seed and root are being used in herbal
medicine as enema, orally as tea to control high blood
pressure and tonic to strengthen the bladder [2,3]. Other
ayurvedic uses of the plant includes treatment of nose
bleeding, hematoma, skin blemishes due to it’s bleaching
properties, halitosis, ear ache, otitis, and as an emenagogue
favouring menstruation and alleviating it’s pains. The
myristicin and apiole contained in the plant have the prop-
erties to increase the production of oestrogen which make
their use relevant in menopause. However, large amountntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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dicated in pregnancy and ingestion of more than 10 drops
a day of the oil may cause abortion. Parsley is also widely
used as a galactofuge by lactating mothers to stop excessive
milk production [4,5].
Although, the use of the plant is discouraged in heart
and kidney disorders due to its water retention capabil-
ities, however, its anti inflammatory and probable immune
boosting properties make it relevant in the traditional
treatment of urinary tract infection, nephritis, cystitis and
prevention of renal stones formation. In addition, it is also
a common home remedy for obesity and reduction of
itching in insect bites [5]. Peteroselinum crispsum in-
creases diuresis by inhibiting the Na+/K+ - ATPase pump
in the kidney, thereby enhancing sodium and water excre-
tion while increasing potassium resorption [6,7].
With reference to herb-drug interactions, Parsley has
been known to interfere with warfarin (Coumadin) treat-
ment due to it’s high content of vitamin K [8]. It’s use is
also contraindicated in diuretic treatment with potential
of causing excessive loss of water. In addition, patients
on aspirin therapy should avoid ingesting Parsley due to
possible increased sensitivity and allergic reactions [4,8].
The presence of myristicine, a narcotic which affects the
central nervous system can interfere with opoid therapy
and when ingested in excess may cause convulsions and
serotonin syndrome [9,10].
It is pertinent to note that the ingestion of the plant is
toxic to many domestic animals including horses, cats
and dogs due to the action of furocoumarins causing
symptoms such as photosentisization, ulcerative and
exudative dermatitis and ocular toxicity that may require
veterinary consultation [11].
Consideration should also be giving to sources of plant
cultivation due to the fact that resorption of heavy
metals by the plants has been observed in soil irrigated
with untreated waste water making the plant a potential
source of heavy metal toxicity [12].
Phytochemically, the leaves and seeds of P. crispum has
been shown to contain high levels of essential oil known
as apiole, while the tender buds contain psoralen and
related compounds that can induce photosensitivity
and these include xanthotoxin, ficusin, bergapten,
majudin, heraclin and antimicrobial furocoumarins namely
8-methoxypsoralen, 5-methoxypsoralen, oxypuecedanin,
isopimpinellin, 6’-acetylopin and a new monoterpene
glycoside [13-15]. The seed also contains cafiolene, beta-
phelandrene, myrcene, fat and myristicin. Furthermore, the
plant is a good source of iron, calcium, phosphorous and
antioxidants like luteolin, vitamin C, vitamin A and zinc
and these may likely account for it’s hepato protective
effect [16,17]. However, in one study, combined treatment
of rat with CCl4 and P. crispum extract demonstrated both
synergistic and antagonistic effects on the liver [18].While phytochemical and pharmacological experiments
with P. crispum extract have been undertaken with dispar-
ity on its hepatotoxic effect, toxicity testing using bio-
chemical and haematological data are not available. This
present study evaluated the toxic effects of the extract of
P.crispum on two target organs; liver and kidney, some
plasma biochemical and haematological parameters.
Methods
Animals
The experimental protocol and procedures used in this
study were approved by the Animal Ethics Committee of
Ladoke Akintola University of Technology Osogbo Campus,
Osun State, Nigeria; and conform to the Guide of Care and
Use of Animals in Research and Teaching (published by the
Animal Ethics Committee of Ladoke Akintola University of
Technology Osogbo Campus, Osun State, Nigeria). Twenty-
four wistar albino rats (220–250 g) of both sexes, divided
into four groups of six animals in each group were used for
the experiment. All animals were maintained on standard
pellet diet (Ladokun Feeds, Nigeria limited) and water
ad libitum.
Plant materials
Petroselinum crispum (Parsley) fresh leaves were col-
lected at Osogbo in the southern part of Nigeria. The
leaves were identified by a taxonomist at the herbarium
of the Federal Institute of Forest Research Ibadan where
voucher specimen was deposited with Voucher Number
126698.
Preparation of plant extract
Petroselinum crispum (Parsley) fresh leaves (1 kg) were
air-dried at room temperature. The air-dried leaves of
the plant were milled into fine powder in a Waring com-
mercial blender. The powdered leaves were macerated in
500 ml ethanol at room temperature (27 ± 1 C) and
extracted for 48 hours with occasional shaking. The sol-
uble ethanol extract was filtered and concentrated to
dryness under reduced pressure at 60 ± 1°C in rotary
evaporator. Freeze-drying and solvent elimination of the
resulting ethanol extract was weighed and finally gave
40.35 g. The percentage yield was calculated using this
formula: weight of extract/original weight × 100 giv-
ing4.0.35% yields) of brown powdery crude Petroselinum
crispum leaf ethanol extract (PCE). The plant extract
was stored in the refrigerator and aliquot of the concen-
trations were prepared immediately before use and was
found to be stable throughout the duration of the
experiment.
Administration of the extract
Separate groups of animals were given oral doses of the
extract at 10, 100 and 1000 mg/kg body weight daily for
Table 1 Effects of oral treatment of varying doses of ethanol from Petroselinum crispum on biochemical parameters in
rats
Treatment Dose mg/kg Liver weight(g) Body weight(g) TP (g/dl) ALB (g/dl) AST (IU/L) ALT (IU/L) ALP (IU/L) BUN (mg/dl)
control - 1.36 ± 0.1 235 ± 4.0 8.0 ± 0.1 4.0 ± 0.1 44.0 ± 1.0 77 ± 2.0 77.0 ± 2.0 16.0 ± 1.0
PSE 10 1.14 ± 0.1 235 ± 4.0 7.9 ± 0.1 4.1 ± 0.1 44.0 ± 1.0 77 ± 2.0 78.0 ± 2.0 17.0 ± 1.0
PSE 100 1.11 ± 0.1 234 ± 4.0 T.8 ± 0.1 3.9 ± 0.1 45.0 ± 1.0 78 ± 2.0 77.0 ± 2.0 18.0 ± 1.0
PSE 1000 1.16 ± 0.1 235 ± 4.0 7.9 ± 0.1 3.8 ± 0.1 45.0 ± 1.0 88 ± 2.0 89.0 ± 2.0* 19.0 ± 1.0*.
*P < 0.05 when compared with control, TP = Total protein, ALB = Albumin, AST = Aspartate amino-transferase,
ALT = Alanine amino- transferase, AP = Alkaline phosphate, BUN = Blood Urea Nitrogen.
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the 5% Tween 80 in saline.
Parameters
Clinical signs and death were observed daily, while weekly
body weight was recorded for each animal. Blood samples
were obtained after eight weeks of oral administration of
the under light anaesthesia from the orbital sinus using
heparinised microhaematocrit tubes according to the
method of [19] and modified by [20]. Plasma was separated
by centrifugation of blood samples at 3000 rpm for 5 -
minutes [21]. The plasma thus obtained was used in the
determination of biochemical parameters were measured
using Randox Laboratories, UK reagent kits.
The activity of aspartate amino transferase (AST) and ala-
nine amino transferase (ALT) were determined colorimetri-
cally at 546 nm using a standard method [22]. Alkaline
phosphatase (AP) was measured using colometric method
described by [23]. Total plasma protein (TP) values were
measured colorimetrically at 546 nm using the biuret
method [24]. Plasma albumin (ALB).concentration was
measured colorimetrically at 630 nm using bromocresol
green method [25]. The concentration of blood urea nitro-
gen (BUN) was determined colorimetrically at 546 nm using
the urease cleavage Berthelot’s reaction described by [26].
Orbital sinus blood sample was obtained weekly in
EDTA for haematological examination. The parameters
measured were hemoglobin Concentration (Hb), packed
cell volume (PCV), red blood cells (RBCs), platelets count
white blood cells (WBCs), differential wbcs counts and
erythrocytes indices; mean corpuscular volume (MCV),
using automated Sysmex KX-21 haematology analyzer.
All animals were sacrificed by exsanguinations after light
ether inhalation anaesthesia at the end of the experiment.Table 2 Effects of orals treatment with varying doses of etha
biochemical parameters in rats
Treatment Dose mg/kg PCV (%) Hb (g/dl) RBC X106/μL WB
Control - 47.7 ± 4 15.5 ± 0.2 6.3 ± 0.1 15.
PCE 10 47.8 ± 4 15.6 ± 0.2 6.2 ± 0.1 15.
PCE 100 48.3 ± 4 16.0 ± 0.2 6.1 ± 0.1 16.
PCE 1000 47.7 ± 4 16.0 ± 0.2 6.3 ± 0.1 17.
*P < 0.05, compared to control, PCV = Packed cell Volume, Hb = Haemoglobin, RBC =
Neutrophils, L = Lymphocyte, M =Monocyte, E = Eosinophils.The animals were subjected to post-mortem examination
with collection of samples from the liver, heart, kidneys
spleen pancreas, lymph nodes, stomach, intestines, Payer's
patches, urinary bladder and lungs. The tissues were fixed in
10% neutral buffered formalin for at least 48 h. 4–5 μm par-
affin sections were processed and stained with haematoxylin
and eosin for microscopic examination using established
protocols [27].
Data analysis
Data were expressed as mean ± SEM. Statistical analyses
was performed by one-way, ANOVA followed by Dunnett’s
test. P values < 0.05 were considered significant.
Results
There were no abnormal signs of toxicity or death recorded
after the eight weeks of treatment at the dose range of 10-
1000 mg/kg body weight. Body weight gradually increased
at these doses comparable with that of control (Table 1).
The activity of aspartate amino transferase (AST),
showed no significant change in all dose levels studied. At
doses of 10 or 100 mg/kg body weight compared to the
control, there was also no significant change in the activity
of ALT. However, a significant increase was observed at
the dose of 1000 mg/kg (Table 1). The activity of plasma
ALP increased at doses of 100 and 1000 mg/kg, but no
significant difference was observed at lower doses of
10 mg/kg and 100 mg/kg.
BUN level at the dose of 1000 mg/kg was significantly
higher than in the control; however there was no signifi-
cant difference at the doses of 10 and 1000 mg/kg com-
pared to the control. There was no significant difference
in the values of TP and ALB at all dose levels studied
(Table 1).nol extract from Petroselinium crispum on haematological
C X103/μL MCV (fl) N (%) M (%) L (%) E (%)
2 ± 0.5 60.0 ± 0.4 18.6 ± 1 80.7 ± 1.0 0.3 ± 0.1 0.4 ± 1.0
5 ± 0.5 60.6 ± 0.4 18.7 ± 1 80.7 ± 0.9 0.3 ± 0.1 0.3 ± 0.8
5 ± 0.5 60.1 ± 0.4 18.1 ± 1 80.6 ± 0.9 0.4 ± 0.13* 0.3 ± 0.8
5 ± 0.5 60.0 ± 0.4 18.0 ± 1 82.1 ± 1.0 0.5 ± 0.17* 0.3 ± 0.8
Red blood cell, MCV =Mean corpuscular volume, WBC =White blood cell, N =
Figure 1 A: Histological section of liver of the control rat (H&E x100). Section showing normal hepatocytes. B: Histological section of test rat
liver at a dose of 100 mg/kg (H&E x100). Showing moderate to normal hepatocytes in extract- treated animals at 100 mg/kg. C: Histological
section of test rat liver at a dose of 1000 mg/kg (H&Ex100). Showing severe degeneration, necrosis and mild to moderate inflammatory reaction
in extract treated animals at 1000 mg/kg.
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http://www.biomedcentral.com/1472-6882/13/75There were no significant differences in the erythrocytic
parameters. PCV was not affected by all the dose levels
studied. There was also no significant difference in
haemoglobin concentration, RBC and MCV at all dose
levels. There was however significant differences in WBC
values at doses of 100 and 1000 mg/kg compared to that
of 10 mg/kg and control. In the differential leukocyte
count, neutrophils showed significant difference at theFigure 2 A.: Histological section of kidney of control rat (H&E x400). S
tubules. B: Histological section of test rat kidney at dose of 100 mg/kg (H&
treated animals. C: Histological section of test rat kidney at dose of 1000 m
surrounding Bowman’s capsule, diffuse tubular necrosis in extract-treated adose levels of 100 and 1000 mg/kg compared to the values
at the dose of 10 mg/kg and control, while lymphocyte,
monocyte and eosinophil counts showed no significant
difference at all dose levels compared to control (Table 2).
There were no overt pathological lesions at lower dose
levels studied. However, at doses ≥ 1000 mg/kg, histopatho-
logical changes including inflammation and necrosis were
observed in both kidney and liver tissues (Figures 1 and 2).ection showing normal histological features including glomerulus and
E x400). Section showing an intact glomerulus and tubules in extract-
g/kg (H& E x400). Section showing a glomerulus with loss of
nimals at 1000 mg/kg.
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Daily oral doses of the extract up to 100 mg/kg did not
cause any obvious clinical abnormalities or death after
eight weeks of treatment.
The estimation of some biochemical parameters such
as the activities of enzymes in tissues and body fluids
plays a major role in disease investigation, diagnosis and
liver toxicity [28,29]. The biochemical parameters in the
test group were to a large extent similar to the control
at a dose of 100 mg/kg.
BUN values and ALT activity at a dose of 1000 mg/kg
was significantly increased compared to the controls. The
significant change in plasma ALT activity with insignifi-
cant change in plasma AST at the dose of 1000 mg/kg
indicates that the extract caused mild changes in the liver.
ALT is a cytoplasmic enzyme and increase in plasma is an
indication of mild injuries caused by drugs to the liver.
Liver injury is characterized as hepatocellular when there
is predominant elevation of the ALT, while AST is a mito-
chondria enzyme whose increase activity in plasma
reflects severe tissue injuries [30].
In the present study, the extract caused increase in ALT
at a dose of 1000 mg/kg with AST and ALP activities fall-
ing within the normal limits at all dose levels. This indi-
cates that the liver injury at a dose of 1000 mg/kg observed
as reflected by an increase in ALT activity is hepatocellular
and not cholestatic or intrabiliary in origin [31-33].
The observed dose- related significant increase in
BUN values at a dose of 1000 mg/kg suggests that the
extract at this oral dose level would cause renal damage.
Hypo-proteinaemia a common finding in liver damage
[29], was not observed in the present study, the total
plasma proteins and albumin concentrations were not
significantly affected at all dose levels. These findings in-
dicate that the extract would not cause any overt liver
damage at the dose levels studied. The non significant
increase or decrease in the haematological values, is an
indication that the extract does not affect the
haemopoetic system when administered orally at the
doses used in this study.
Furthermore, there were no discernable lesions at the
dose up to 100 kg/mg. These findings further showed
that the effect of the extract on target tissues namely
liver and kidney as shown by biochemical data, is insig-
nificant at the dose levels used. Therefore, the observed
significant increase in plasma levels of ALT and BUN at
1000 mg/kg might have been caused by sub-cellular
tissue changes.
It is plausible to infer that the ethanol extract of
Petroselinum crispum is not toxic when administered
orally at doses of 10-100 mg/kg for 8 weeks in rats.
However, daily oral dose of 1000 mg/kg or greater can
cause liver and kidney damage after 8 weeks of contin-
ued administration.It is therefore expedient to advise that caution should be
exercised in the use of Parsley in treatment of ailments to
avoid overdosing bearing in mind the challenge of
standardised dosing in herbal medicine due to paucity
of information on pharmaco-genetics and pharmaco-
dynamics of herbal preparations. In addition, consideration
should be given to the potential toxicity of ingestion of
Parsley with allopathic medication with serotonin activity.
Furthermore, ingestion of parsley should be discouraged in
pregnancy, lactating mothers and in individuals on opiods,
lithium salts, diuretics and warfarin therapy due to poten-
tial drug-herb interaction [4,9,34]. Because Parsley bio-
accumulate toxic heavy metals [12], it’s cultivation should
not be done on soil irrigated with untreated waste water.
Conclusion
These results indicate that the leaf ethanol extract of
Petroselinum crispum was mildly hepatotoxic and
nephrotoxic at continued oral doses equal to or more
than 1000 mg/kg. It was concluded that the extract does
not cause any obvious toxicity when used at lower doses,
it is therefore expedient for users to exercise caution in
its administration to avoid overdosing. In circumstances
of possible contraindications like pregnancy, lithium in-
gestion as common in psychiatric patients, warfarin and
opiods therapies, it’s use should be avoided. In addition,
plant source should not be from soil irrigated with waste
water.
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